265 filings
Page 8 of 14
8-K
62j9aznq1
7 May 14
Results of Operations and Financial Condition
12:00am
8-K
bb6xudyc95r7
2 May 14
Immunomedics Prices $30 Million Public Offering of Common Stock
12:00am
8-K
cztit5 enk2
7 Mar 14
Entry into a Material Definitive Agreement
12:00am
8-K
hyxsnu
10 Feb 14
Results of Operations and Financial Condition
12:00am
8-K
ou1yq
4 Dec 13
Submission of Matters to a Vote of Security Holders
12:00am
8-K
7zd9ku
4 Nov 13
Results of Operations and Financial Condition
12:00am
8-K
5v8xwde6zqlwf
9 Oct 13
Immunomedics Announces Termination of Agreement and Return of Worldwide Rights to Veltuzumab for All Non-cancer Indications
12:00am
8-K
33d2vc5era7z4n 0u
4 Oct 13
Changes in Registrant's Certifying Accountant
12:00am
8-K
86zw4z1udyhd1n9v
5 Sep 13
Entry into a Material Definitive Agreement
12:00am
8-K
a0t7n5q0n0 ck04b7ic
22 Aug 13
Results of Operations and Financial Condition
12:00am
8-K
mbee2ifbz1ydxi6
22 Aug 13
Departure of Directors or Certain Officers
12:00am
8-K
djwyz52fxjjz23h
20 Aug 13
Departure of Directors or Certain Officers
12:00am
8-K
rmbwssfg0ky
8 May 13
Results of Operations and Financial Condition
12:00am
8-K
tbpf xp351jiq
1 Apr 13
Other Events
12:00am
8-K
s2xlqlya0p rc2
27 Feb 13
Immunomedics Announces Closing of Public Offering and Full Exercise of Overallotment Option by Underwriters
12:00am
8-K
9c3fk owl9f3w4hxd
22 Feb 13
Immunomedics Prices $14.0 Million Public Offering of
12:00am
8-K
m9zuql8rs
7 Feb 13
Results of Operations and Financial Condition
12:00am
8-K
s8skhphkpi7kvbopva
6 Dec 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
g56m8yp0p 9zx4esc
8 Nov 12
Results of Operations and Financial Condition
12:00am
8-K
bbk2fcvlfpx2n51
30 Aug 12
Departure of Directors or Certain Officers
12:00am